Annual report pursuant to Section 13 and 15(d)

SEGMENT INFORMATION (Tables)

v3.10.0.1
SEGMENT INFORMATION (Tables)
12 Months Ended
Nov. 30, 2018
Nov. 30, 2017
Schedule of Segment Information [Table Text Block]
                Corporate        
          PT     and        
    CDMO     Business     Eliminations     Consolidated  
    (in thousands)  
Revenues from external customers $ 22,582   $   -   $ (3,927 ) $ 18,655  
Cost of revenues   (11,541 )         1,235     (10,306 )
Segment gross profit (loss)   11,041     -     (2,692     8,349  
Research and development expenses, net   (39 )   (7,931 )   2,485     (5,485 )
Operating expenses   (6,889 )   (6,224 )   207     (12,906 )
Other expenses   (77 )   -           (77 )
Segment operating profit (loss)   4,036     (14,155 )   -     (10,119 )
Adjustments to presentation of segment Adjusted EBIT                    
     Depreciation and amortization   (2,613 )   (11 )         (2,624 )
Segment performance   1,423     (14,166 )         (12,743 )
                Corporate        
          CT     and        
    CDMO     Business     Eliminations     Consolidated  
    (in thousands)  
Revenues from external customers $ 11,484   $   -   $ (1,395 ) $ 10,089  
Cost of revenues   (6,356 )         638     (5,718 )
Gross profit   5,128     -     (757 )   4,371  
Research and development expenses, net         (2,517 )   757     (1,760 )
Operating expenses   (4,699 )   (3,335 )         (8,034 )
Operating profit   429     (5,852 )   -     (5,423 )
Adjustments to presentation of segment Adjusted EBIT                        
     Depreciation and amortization               (2,720 )   (6 )
Segment performance               (2,291 )   (5,858 )
Schedule of Reconciliation of Segment Performance [Table Text Block]
    Year ended  
    November 30,  
    2018  
    in thousands  
Segment subtotal performance   (12,743 )
Stock-based compensation   (4,364 )
Financial expenses, net   (2,938 )
Net gain on remeasurement of previously equity interest in Atvio and CureCell to acquisition date fair value   4,509  
Transaction expenses related to GPP agreement   (1,500 )
Share in losses of associated companies   (731 )
Loss before income tax   (17,767 )
Reconciliation of segment performance to loss for the year:   Year ended  
    November 30,  
    2017  
       
    in thousands  
    Segment performance   (8,149 )
   Stock-based compensation   (3,364 )
   Financial income (expenses), net   (950 )
   Share in losses of associated company   (1,214 )
   Loss before income tax $ (13,677 )
Schedule of Revenues from Major Customers [Table Text Block]
    Year Ended     Year Ended  
    November 30,     November 30,  
    2018     2017  
    (in thousands)  
Customer A $ 2,338   $ 4,115  
Customer B $ 4,374   $ 2,837  
Customer C $   -   $ 2,055  
Customer D $ 5,236   $   -  
Customer E $ 2,242   $   -